insights_auto
Why is 000739 down 9,09%?
Dive Deeperchevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
21,29 CN¥
arrow_downward
-9,09%(-2,13) 1D
19 қаз., 10:33:45 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
23,02 CN¥
High
23,57 CN¥
Low
21,08 CN¥
Mkt. cap
27,13 млрд
Avg. vol.
16,57 млн
Volume
19,75 млн
Dividend
1,77%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026 ж. 08 қаз.
P/E ratio
28,89
52-wk high
28,50 CN¥
52-wk low
14,89 CN¥
EPS
0,74 CN¥
Shares outstanding
1,16 млрд
No. of employees
7 мың
Open
23,02 CN¥
High
23,57 CN¥
Low
21,08 CN¥
Mkt. cap
27,13 млрд
Avg. vol.
16,57 млн
Volume
19,75 млн
Dividend
1,77%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026 ж. 08 қаз.
P/E ratio
28,89
52-wk high
28,50 CN¥
52-wk low
14,89 CN¥
EPS
0,74 CN¥
Shares outstanding
1,16 млрд
No. of employees
7 мың
News stories
From web sources and news partners
TradingView
·
1 сағат бұрын
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
The Fintech Times
·
34 минут бұрын
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
·
1 сағат бұрын
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
·
4 сағат бұрын
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd